Bank Julius Baer & Co. Ltd, Zurich
BankPosition in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1544599
ZURICH, V8
Position in ALNY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,989,572
+$595,288 QoQ
Shares Held
16,575
+24.8% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#241
of 780 holders
Holding Since
Dec 2023
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank Julius Baer & Co. Ltd, Zurich holds $177,704,514 across 10 Biotechnology names. ALNY ranks #4 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
319,371 | $158,641,156 | |
| 2 | MRNA |
Moderna, Inc.
|
93,920 | $6,577,217 | |
| 3 | BNTX |
BioNTech SE
|
61,701 | $5,741,278 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
16,575 | $4,989,572 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
13,178 | $718,728 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
12,000 | $468,120 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
718 | $447,701 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
1,710 | $58,687 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,989,572 | 16,575 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,394,284 | 13,281 | Shares | Sole | 2026-05-05 | |
| 2023-12-31 | $415,742 | 2,172 | Shares | Sole | 2024-05-16 | |
| No filing history on record for this holder in this stock. | ||||||